Select Page

Valeant Pharmaceuticals Adds Board Members

Valeant Pharmaceuticals, which is currently being questioned by Congress and investigated by federal law enforcement agencies for allegedly buying old drugs and raising their prices, has added three new members to its board: Stephen Fraidin, vice chairman of Pershing...

McKesson Will Purchase Vantage Oncology

McKesson has signed official papers to purchase Vantage Oncology in a 1.2 billion dollar transaction. With this development, McKesson will acquire “more than 50 cancer centers across thirteen states.” Paul Julian, the executive vice president and group president of...

Recap: Martin Shkreli’s pharmaceutical saga

Martin Shkreli gained notoriety in the medical industry after a widely publicized decision to increase the price of a decades-old drug by more than 5,000 percent in September 2015. Mr. Shkreli’s company, Turing Pharmaceuticals, raised the price of toxoplasmosis drug...